Abstract
Weeks and even months after recovering from the SARS-CoV-2 infection, clinically more severe cases are being reported, which are suggestive of COVID-19-related multisystemic inflammatory syndromes (MIS). Firstly on March 2020, this condition was reported to be COVID-19 related to children (MIS-C). Since June 2020, a syndrome similar to multisystem inflammatory syndrome in adults (MIS-A) came to be noticed in adults as well. We reported here a case of 24-year-old young woman who had gone to a hospital with abdominal pain and later developed a severe cough, followed by development of subconjunctival bleeding, pericardial effusion, pleural effusion, and intra-abdominal fluid that we deemed them to be acute multisystemic clinical symptoms, 47 days after she had undergone a COVID-19 infection of mild clinical severity. It should be kept in mind that a multisystemic inflammatory syndrome along with a delayed immune response during COVID-19 disease can be seen not only in children but also in young adults, and seemingly severe clinical and laboratory findings can improve by controlling the inflammatory process.
Author supplied keywords
Cite
CITATION STYLE
Altunisik Toplu, S., Ersoy, Y., Bayindir, Y., Kilic, T., & Bayazit, V. (2021). Multisystem inflammatory syndrome in adults (Mis-a) associated with sars-cov-2 infection in a young adult case from turkey. Medeniyet Medical Journal, 36(2), 180–184. https://doi.org/10.5222/MMJ.2021.95422
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.